Oxford Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Oxford Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4M	Buy	109,917 +12,651	+13%	+$1.71M	8.55%	1
2026 Q1	$12.4M	Buy	97,266 +42,960	+79%	+$5.36M	5.01%	1
2025 Q4	$6.62M	Sell	54,306 -70,283	-56%	-$8.06M	2.34%	1
2025 Q3	$12.5M	Sell	124,589 -89,685	-42%	-$8.08M	4.09%	1
2025 Q2	$17.8M	Buy	214,274 +134,151	+167%	+$10.7M	5.82%	1
2025 Q1	$6.5M	Buy	80,123 +16,676	+26%	+$1.49M	2.97%	1
2024 Q4	$5.71M	Buy	63,447 +19,803	+45%	+$1.92M	2.54%	1
2024 Q3	$4.31M	Buy	43,644 +2,396	+6%	+$235K	3.59%	1
2024 Q2	$3.82M	Buy	+41,248	New	+$3.7M	3.72%	1

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Oxford Asset Management's XBI Position: Q2 2026 in Review

Oxford Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q2 2026, buying an estimated $1.71M and bringing the position to 109,917 shares worth $17.4M. The position accounts for 8.55% of the portfolio, ranked #1.

Oxford Asset Management first reported a position in XBI in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.8M in Q2 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Oxford Asset Management held 109,917 shares of State Street SPDR S&P Biotech ETF worth $17.4M as of Q2 2026.
Oxford Asset Management bought 12,651 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.71M.
State Street SPDR S&P Biotech ETF made up 8.55% of Oxford Asset Management's portfolio in Q2 2026, its #1 holding.
Oxford Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 9 quarters since.
Oxford Asset Management's State Street SPDR S&P Biotech ETF position peaked at $17.8M in Q2 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.